Cargando…
_version_ 1782266063367438336
author Jung, Chul Won
author_facet Jung, Chul Won
author_sort Jung, Chul Won
collection PubMed
description
format Online
Article
Text
id pubmed-3625002
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-36250022013-04-15 Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome Jung, Chul Won Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2013-03 2013-03-25 /pmc/articles/PMC3625002/ /pubmed/23589801 http://dx.doi.org/10.5045/br.2013.48.1.68 Text en © 2013 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Jung, Chul Won
Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title_full Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title_fullStr Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title_full_unstemmed Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title_short Ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
title_sort ruxolitinib changes the natural course of myelofibrosis and its transplant outcome
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625002/
https://www.ncbi.nlm.nih.gov/pubmed/23589801
http://dx.doi.org/10.5045/br.2013.48.1.68
work_keys_str_mv AT jungchulwon ruxolitinibchangesthenaturalcourseofmyelofibrosisanditstransplantoutcome